Cancer Diagnosis, Prevention & Therapeutics Review Branch – CDPT
Dr. Syed Quadri
Chief
Review Branch Summary
The CDPT Review Branch will consider applications involving translational and clinical investigations including clinical trials that encompass cancer prevention, diagnosis and treatment. Specifically, the CDPT Review Branch reviews research grant applications related to immune therapies for cancer; the translation of cancer research to clinical practice; chemoprevention; and the development of biomarkers/signatures for tumor detection and diagnosis.
Study Sections
- Cellular Immunotherapy of Cancer CIC
- Cancer Prevention Study Section CPSS
- Clinical Oncology Study Section*Modified scope for May/June 2022 grant deadlines and Fall 2022 review meetings CONC
- Oncology 2 - Translational Clinical Small Business SBIR/STTR Special Emphasis Panels Cancer Biotherapeutics Development (CBD) SBIR/STTR SEPCDPT (12)
- Oncology 2 – Translational Clinical Small Business SBIR/STTR Special Emphasis Panels Cancer Diagnostics and Treatments (CDT) SBIR/STTR SEPCDPT (13)
- Fellowships: Oncological Sciences F09C
- Molecular Cancer Diagnosis and Classification MCDC
- Translational Immuno-oncology TIO
- Therapeutic Immune Regulation TIR
